Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2019-08-12 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
关于使用部分暂时闲置募集资金进行现金管理及暂时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the use of temporarily idle raised funds for cash management and temporary replenishment of working capital. It includes details about the board and supervisory committee meetings approving the use of funds, investment products, risk control measures, and opinions from independent directors and the sponsor institution. The document references regulatory approvals and compliance with securities regulations. It does not contain financial statements or detailed financial performance data but rather discloses a specific financing-related activity and compliance information. This fits the definition of a Capital/Financing Update (CAP) as it updates on the company's use of raised funds and capital management activities.
2019-08-12 Chinese
独立董事关于使用部分暂时闲置募集资金进行现金管理及暂时补充流动资金的独立意见
Regulatory Filings
2019-08-12 Chinese
公司章程
Regulatory Filings
2019-07-18 Chinese
首次公开发行股票科创板上市公告书
Regulatory Filings
2019-07-18 Chinese
首次公开发行股票并在科创板上市招股说明书
Capital/Financing Update Classification · 95% confidence The document is titled as a 招股说明书, which translates to a prospectus or an IPO prospectus. It contains detailed information about the company's stock issuance, risk factors, financial data, governance, and other disclosures related to the initial public offering and listing on the Shanghai Stock Exchange Science and Technology Innovation Board (科创板). It includes extensive financial data, risk disclosures, business overview, governance, and other sections typical of an IPO prospectus. This type of document is not an annual report, earnings release, or any other category listed but is specifically a prospectus for a stock issuance and listing. The closest fitting category from the provided list is "Capital/Financing Update (CAP)" because it relates to the company's fundraising and capital structure changes through the IPO process. The document is lengthy (15,000 characters) and contains substantive financial and business information, not merely an announcement or certification. Therefore, the classification is CAP with high confidence.
2019-07-16 Chinese
首次公开发行股票并在科创板上市发行结果公告
Regulatory Filings
2019-07-16 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.